Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_assertion type Assertion NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_head.
- NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_assertion description "[mRNA levels of CD95L correlated positively (r=0.90; p< 0.01) and transmembrane CD95 inversely (r=-0.88; p< 0.01) with histopathological grading of the breast tumours: CD95L mRNA levels were low in adenomas, but increased by 20-fold in grade I, 120-fold in grade II, and 310-fold in grade III breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_provenance.
- NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_assertion evidence source_evidence_literature NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_provenance.
- NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_assertion SIO_000772 10547600 NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_provenance.
- NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_assertion wasDerivedFrom befree-2016 NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_provenance.
- NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_assertion wasGeneratedBy ECO_0000203 NP266860.RAE598xm8A418P_jTPbshFC7TnIiXkxnKlY1T46UrYzd0130_provenance.